Gene therapy helps patients with hemophilia B.
An experimental gene therapy technique boosted the production of a vital blood clotting factor in six people with hemophilia B, according to new research supported by the National Institutes of Health. The therapy could give patients a long-term solution for preventing prolonged bleeding episodes and spontaneous bleeding.
To read the full text of this article, click here: http://www.nih.gov/news/health/dec2011/nhlbi-12.htm
|Printer friendly Cite/link Email Feedback|
|Publication:||National Institutes of Health: News and Events|
|Article Type:||Brief article|
|Date:||Dec 12, 2011|
|Previous Article:||Ambassador Eric Goosby, U.S. Global AIDS Coordinator, to deliver Barmes Lecture at National Institutes of Health.|
|Next Article:||NDAR federation creates largest source of autism research data to date.|